"With Inari as the mechanical thrombectomy leader in pulmonary embolism (PE) and deep vein thrombosis (DVT), Inari's products could now bolster the neurovascular subsegment that represents a $1.3 ...

Key barriers in adhering to anticoagulation guidelines included uncertainty about its choice, established practices, and the ...

Inari Medical’s product portfolio includes medical devices that treat pulmonary embolism, deep vein thrombosis, in-stent thrombosis and arteriovenous fistula. Stryker said the products are “hi ...

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

It includes mechanical thrombectomy solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. “The acquisition of Inari expands Stryker's portfolio to ...

Inari is poised to enhance Stryker's footprint ... These solutions are designed to treat peripheral vascular conditions such as pulmonary embolism and deep vein thrombosis. They claim to remove ...

Inari shareholders are getting a fair price ... and has not really been a player in venous markets like pulmonary embolism (or PE), deep vein thrombosis (or DVT), limb ischemia, and the like ...

Inari, established in 2011, focuses on providing mechanical thrombectomy solutions for conditions such as deep vein thrombosis and pulmonary embolism, which affect a significant number of ...

Inari, which was founded in 2011 ... solutions for peripheral vascular diseases such as deep vein thrombosis and pulmonary embolism. Each year, VTE impacts up to 900,000 lives in the United ...

The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States. Read More on NARI: Inari Medical NewsMORE Related ...